MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3087568 35 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis. METHODS A literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. RESULTS The literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines. CONCLUSIONS The updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy. © 2014 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.
Έτος δημοσίευσης:
2014
Συγγραφείς:
Lalla, R.V.
Bowen, J.
Barasch, A.
Elting, L.
Epstein, J.
Keefe, D.M.
McGuire, D.B.
Migliorati, C.
Nicolatou-Galitis, O.
Peterson, D.E.
Raber-Durlacher, J.E.
Sonis, S.T.
Elad, S.
The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer
International Society of Oral Oncology (MASC/ISOO)
Al-Dasooqi, N.
Brennan, M.
Gibson, R.
Fulton, J.
Hewson, I.
Jensen, S.B.
Logan, R.
Öhrn, K.E.O.
Sarri, T.
Saunders, D.
von Bültzingslöwen, I.
Yarom, N.
Allemano, J.
Al-Azri, A.R.
Antunes, H.S.
Ariyawardana, A.
Bateman, E.
Blijlevens, N.
Boers-Doets, C.B.
Bossi, P.
Brown, C.G.
Chang, Y.-C.
Cheng, K.K.
Cooksley, C.
Correa, E.P.
Dennis, K.
Di Palma, M.
Drucker, S.
Eilers, J.
Escalante, C.
Estilo, C.L.
Everaus, H.
Fijlstra, M.
Fliedner, M.
Freidank, A.
Gerber, E.
Gibson, F.
Gomez, J.G.
Halm, J.
Hita, G.
Hutchins, R.D.
Hodgson, B.
Hovan, A.
Jarvis, V.
King, E.E.
Kouloulias, V.E.
Latortue, M.C.
Lees, J.
Lopes, N.N.F.
Loprinzi, C.
Michelet, M.
Mori, T.
Nair, R.G.
Niscola, P.
Oberle-Edwards, L.K.
Osaguona, A.
Parelkar, P.
Park, J.
Parker, I.
Pettersson, B.G.
Potting, C.
Rao, N.G.
Riesenbeck, D.
Rouleau, T.
Schubert, M.M.
Silverman, S., Jr.
Soga, Y.
Spijkervet, F.K.L.
Stokman, M.
Stringer, A.M.
Tissing, W.J.E.
van der Velden, W.J.F.M.
van de Wetering, M.D.
Vithala, M.
Weikel, D.S.
Yazbeck, R.
Yeoh, E.
Zadik, Y.
Περιοδικό:
JMIR Cancer
Εκδότης:
John Wiley and Sons Inc
Τόμος:
120
Αριθμός / τεύχος:
10
Σελίδες:
1453-1461
Λέξεις-κλειδιά:
acetylsalicylic acid; amifostine; benzydamine; chlorhexidine; doxepin; glutamine; granulocyte colony stimulating factor; granulocyte macrophage colony stimulating factor; iseganan; misoprostol; morphine; octreotide; palifermin; pentoxifylline; pilocarpine; probiotic agent; salazosulfapyridine; sucralfate; zinc sulfate, cancer chemotherapy; cancer radiotherapy; cancer therapy; cryotherapy; diet supplementation; gastrointestinal mucositis; head and neck cancer; health care policy; human; hyperbaric oxygen; low level laser therapy; lozenge; mouth cavity; mouth hygiene; mucosa inflammation; oral mucositis; patient controlled analgesia; phototherapy; practice guideline; priority journal; review; systematic review; whole body radiation, gastrointestinal; guidelines; mucositis; Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO); oral; stomatitis, Amifostine; Analgesics; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antineoplastic Agents; Cryotherapy; Cytokines; Esophagitis; Evidence-Based Medicine; Humans; Hyperbaric Oxygenation; Intercellular Signaling Peptides and Proteins; Laser Therapy, Low-Level; Mucositis; Neoplasms; Oral Hygiene; Phototherapy; Proctitis; Protective Agents; Radiation-Protective Agents; Radiotherapy; Stomatitis; Sucralfate
Επίσημο URL (Εκδότης):
DOI:
10.1002/cncr.28592
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.